A Rundown of Ongoing Psychedelics Clinical Studies The

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
235
A Rundown of Ongoing Psychedelics Clinical Studies

The psychedelics space has grown significantly in the last few years, becoming a full-fledged industry with many verticals that range from specialized healthcare services to digital therapeutics and supply chain solutions. Drug discovery and development is arguably the sector’s most observed vertical given that the approval of psychedelic drugs through the clinical trial pipeline is a one-way ticket to revenue for any companies in this space.

Below is a list of some of the clinical trials being conducted in the psychedelics space.

Ongoing phase 1 clinical trials

Ceruvia Lifesciences
The company is currently conducting clinical trials for its synthetic psilocybin compound dubbed SYNP-101 and its LSD non-hallucinogenic analog known as NYPRG-101. SYNP-101 is being studied for its use in treating obsessive-compulsive disorder as well as cluster and migraine headaches.

Beckley Psytech
This arm of the Beckley Foundation is recruiting for its phase 1 trial, which will evaluate the use of psilocybin in treating chronic short-lasting unilateral neuralgiform headaches.

Phase 1/2 trials

DemeRx
The company announced earlier this year that it had received approval to begin recruiting for its phase 1/2a ibogaine clinical trial in treating opioid use disorder.

Small Pharma
Small Pharma has partnered with Imperial College London’s Centre for Psychedelic Research for a phase 1/2a trial of DMT in treating depression.

Announced phase 2 trials

Eleusis
This company may soon commence phase 2 trials for its two psychedelic infusion therapies for the treatment of major depressive disorder.

MindMed
The company recently announced its plans for phase 2 trials in the use of LSD microdosing in managing pain and ADHD.

MAPS
Multidisciplinary Association for Psychedelic Studies (“MAPS”) is set to begin a phase 2 trial examining MDMA-assisted cognitive behavioral conjoint therapy in the treatment of post-traumatic stress disorder.

Cybin Inc.
Earlier this year, Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) revealed that it had secured approval to begin a phase 2 clinical study evaluating its formulation dubbed CYB001 indicated for the treatment of major depressive disorder.

Ongoing phase 2 trials

MAPS

The association is also exploring the use of MDMA in treating social anxiety in autistic individuals, anxiety linked to a life-threatening ailment, and eating disorders such as binge eating and anorexia nervosa.

Awakn Life Sciences
The company is undertaking a phase 2a/2b trial investigating the use of ketamine in the reduction of alcoholic relapse.

Usona Institute
This not-for-profit organization based in Wisconsin is conducting a phase 2 trial investigating psilocybin use in patients with major depressive disorder.

Compass Pathways
Compass is conducting a phase 2 trial on its COMP360 psilocybin formulation, which has been developed to manage treatment-resistant depression.

To follow these and other ongoing/planned studies, use this interactive tracker to get the latest on any study you may have an interest in.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer







Cybin Inc (CYBN) Stock Research Links

CYBN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tribal Tech Triumph: ILINX Boosts Proposal Efficiency

Updated Category News Views 24

A New Era for Tribal Operations Well, here's a headline that might've slipped under your radar, but it’s got some serious implications. Over in Olympia, Washington, ImageSource, Inc., the brains behind the ILINX platform, just scored a home run with an automated system for crafting Tribal Indirect Cost Rate Proposals (ICRPs). This ain't just gadget talk; this is a...

Continue Reading
FirstEnergy's New Tech to Bolster Pennsylvania Grid

Updated Category News Views 0

Electricity Demand Spurs Grid Innovation The winds of change are blowing across Pennsylvania's power grid. FirstEnergy Transmission's (NYSE:FE) subsidiary, Keystone Appalachian Transmission Company (KATCo), is diving into a significant federally funded project to reinforce grid reliability. With electricity demand on an upward trajectory, Pennsylvania and beyond need...

Continue Reading
EQT's Strategic Moves in Q3 2026 Amid Strong Execution

Updated Category News Views 111

Inside EQT's Third Quarter Performance EQT Corporation has rolled out its third quarter 2026 results, and boy, they’ve been playing their cards with some finesse. The company's sporting a strong showing despite the tricky currents in the natural gas market where prices took a nosedive. What's keeping EQT upright, you ask? It's their smart marketing maneuvers and a...

Continue Reading
Nektar Therapeutics Gears Up for Q3 Financial Reveal

Updated Category News Views 56

Anticipation Builds as Nektar Preps Financial Report Ah, the life of a biotech investor, riding high or gripping the rail as tides turn with every quarterly report. This time, we're turning our gaze to Nektar Therapeutics and their Q3 financial results slated for release on November 12th, just as the market dust starts settling for the day. Now, if you’re wired to...

Continue Reading
Ballard’s HPU Agile-H Poised to Transform Portable Energy

Updated Category News Views 34

Another Step Forward with Hydrogen Ballard's got another ace up its sleeve with the HPU Agile-H. Now here’s the kicker—everyone’s scrambling for cleaner, more portable energy solutions, and Ballard’s stepped up. Born from their acquisition of GeoPura, this lightweight hydrogen powerhouse is engineered for those spots rudely ignored by the grid. Place your bets on...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 0

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Heart Failure Certification Highlights Quality at Two Centers

Updated Category News Views 26

Celebrating Milestones in Healthcare Certification Out there in the Bronx, two skilled nursing facilities just snagged a certification that means they're playing in the big leagues of heart failure care. Holliswood Center and Bushwick Center, both under the Centers Health Care umbrella, have been awarded the Skilled Nursing Facility Heart Failure Certification from none...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 14

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading
Rothera's KPI Swap Approval: A Financial Game Changer

Updated Category News Views 74

Revolutionizing Risk Management with KPI Swaps Boy, if there's one thing that gets my ticker going, it's the buzz of innovation in financial markets. Rothera just landed a CFTC stamp of approval for something that's about to shake up how institutional traders manage risk: Key Performance Indicator (KPI) swaps. And can you believe it? This isn't just another derivative...

Continue Reading
Envision Energy's AI System Targets Green Mining Future

Updated Category News Views 73

The New Frontier: Mining's Green Shift Mining's bustling heart might just get an eco-friendly tune-up. That's the buzz Envision Energy stoked at All Energy Australia with their new AI-powered energy system aimed squarely at the mining and smelting industry. With wind, solar, battery storage, and all kinds of renewable gimmicks, they're striving to make those hulking...

Continue Reading

Top 5 Most Recently Viewed Articles

Abcourt's Progress Update on Sleeping Giant Mine Operations

Updated Category News Views 169

Abcourt Mines Inc. Advances in Sleeping Giant Mine Development Abcourt Mines Inc. (TSX Venture: ABI) (OTCQB: ABMBF) has made meaningful progress in the development of its Sleeping Giant Mine located in Quebec's Eeyou Istchee region. The company commenced material processing in mid-August at its fully owned Sleeping Giant Mill, marking a significant milestone in its...

Continue Reading
Elastic's Open Inference API Enhances Interaction with Google AI

Updated Category News Views 209

Elastic (NYSE: ESTC) made waves in the tech space back in 2024 when it announced that its Open Inference API now integrates seamlessly with Google AI Studio. This wasn't just a PR stunt; this partnership aimed to propel developers into a new realm of machine learning capabilities while optimizing data interactions using Elasticsearch indexes. But let's peel back the...

Continue Reading
Inspirato CEO's Bold Investment Signals Future Growth

Updated Category News Views 136

Inspirato CEO Makes a Bold Move In an impressive turn of events, Payam Zamani, the Chief Executive Officer of Inspirato Inc, has made headlines by purchasing a large number of shares in the company. Recent filings with the SEC show that Zamani acquired an astonishing 1,580,180 shares of Class A common stock in Inspirato Inc (NASDAQ:ISPO), which are valued at around $8.56...

Continue Reading
Guardforce AI Expands AIoT Robot Advertising in U.S.

Updated Category News Views 117

Guardforce AI Expands AIoT Robot Advertising into the U.S. Market Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ: GFAI, GFAIW), a provider of integrated security solutions, AI, and Robot-as-a-Service (RaaS), has announced its plans to expand its Artificial Intelligence of Things (AIoT) Robot Advertising business into the U.S. market. The...

Continue Reading
Pandora's Strategic Share Buyback Programme Explained

Updated Category News Views 126

Understanding Pandora’s Share Buyback Programme Pandora, known as the world's largest jewellery brand, has initiated an exciting share buyback programme. This programme is designed to effectively manage and strengthen the company's share capital while addressing its commitments under various incentive plans. By repurchasing shares, Pandora aims not only to enhance...

Continue Reading